<DOC>
	<DOCNO>NCT02831569</DOCNO>
	<brief_summary>This open-label , single-group , multi-centre trial confirm safety efficacy loxoprofen sodium/methocarbamol ( IP-TN ) administer orally 2 week patient low back pain , scapulohumeral periarthritis , cervico-omo-brachial syndrome associate muscle strain . More 90 patient screen enroll approximately 80 patient trial . After give write informed consent , patient enrol trial . Patients consider eligible trial Investigator consent complete trial procedure assessment Visit 1 receive trial medication enter open-label treatment period 2 week . Patients complete open-label treatment period enter follow-up period 1 week complete trial confirmation last visit ( phone interview ) .</brief_summary>
	<brief_title>Japanese IP-TN Trial</brief_title>
	<detailed_description />
	<mesh_term>Loxoprofen</mesh_term>
	<mesh_term>Methocarbamol</mesh_term>
	<criteria>Inclusion criterion : Male female outpatient age &gt; =15 year time give consent . Patients diagnose low back pain , scapulohumeral periarthritis , cervicoomobrachial syndrome prior give consent . Patients cervicoomobrachial syndrome must associate symptom occipital pain . No medical therapy target disease ( low back pain , scapulohumeral periarthritis , cervicoomobrachial syndrome ) one week prior Visit 1 ( start day treatment ) . Patients meet follow criterion examination conduct start treatment Visit 1 ( start day treatment ) Based patient interview , evaluation site ( low back , shoulder neck ) decide investigator visual analogue scale score &gt; =40 mm ( case evaluation site , investigator determine evaluation sit one site big visual analogue scale score . Visual analogue scale score &gt; =40 mm one pain symptom ( tenderness , listlessness , pain rest , pain motion , nighttime pain , limitation motion ) prior start treatment . Muscle strain evaluation site ( low back , shoulder neck ) diagnose Investigator base patient interview palpation . Patients pain symptoms Visit 1 ( start day treatment ) , Investigator 's opinion , suitable treatment NSAIDs muscle relaxant . Signed date write informed consent accordance Good Clinical Practice local legislation prior admission trial . For minor ( age &gt; =15 &lt; 20 year ) , write informed consent must also obtained legal representative . Exclusion criterion : Bronchial asthma time give consent For patient allergic rhinitis atopic disease , absence bronchial asthma must confirm document source data . Treatment oesophageal , gastric duodenal ulcer erosion within 4 week prior give consent At Visit 1 ( start day treatment ) , patient symptoms evaluation site due injury , tumour , infection rheumatoid arthritis , obvious neurological ( radicular ) symptom ( e.g. , hernia , etc . ) may require surgery trial period At Visit 1 ( start day treatment ) , cervical sprain ( whiplash ) Patients must carry hazardous work work high place drive car trial , Investigator 's opinion , difficult comply protocol . Patients cervicoomobrachial syndrome whose headache clearly different associate symptom occipital pain indistinguishable occipital pain Patients therapy target disease trial ( low back pain , scapulohumeral periarthritis , cervicoomobrachial syndrome ) time give consent plan start new therapy future . The therapy include medical therapy , physical therapy rehabilitation . Using corticosteroid ( oral , injection suppository topical use pain relief ) within 4 week prior Visit 1 ( start day treatment ) The use inhale corticosteroid asthma chronic obstructive pulmonary disease allow . Patients must use prohibited medication treatment trial period Past present alcohol drug abuse Past present clinically significant comorbidities ( serious cardiac , renal , hepatic haematologic disorder , psychiatric disorder , aspirin asthma , etc . ) Investigator 's judgment Any document suspected allergy hypersensitivity individual active ingredient trial medication , analgesic , NSAIDs , sulfa , cyclooxygenase inhibitor lactose Any document active suspected malignancy history malignancy within 5 year prior Visit 1 , except appropriately treat basal cell carcinoma skin situ carcinoma uterine cervix Premenopausal woman ( within 1 year since last menstruation prior give consent ) : lactating pregnant childbearing potential practicing adequate contraception plan use contraception continuously trial refuse take periodic pregnancy test trial . Adequate contraceptive method include tubal ligation , intrauterine device , oral contraceptive , complete abstinence , doublebarrier method male partner 's vasectomy . Receiving investigational product within 4 week prior Visit 1 ( start day treatment ) plan receive investigational product trial . Patients inappropriate subject trial Investigator 's opinion</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>